Scavenging of Reactive Oxygen Species Can Adjust the Differentiation of Tendon Stem Cells and Progenitor Cells and Prevent Ectopic Calcification in Tendinopathy.

Haotian Shen,Linxiang Cheng,Qiangqiang Zheng,Wenduo Liu,Yue Wang
DOI: https://doi.org/10.1016/j.actbio.2022.09.007
IF: 10.633
2022-01-01
Acta Biomaterialia
Abstract:Tendinopathy is a common disorder that leads to pain and impaired quality of life. Recent studies re-vealed that osteogenic differentiation of tendon stem/progenitor cells (TSPCs) played an important role in the pathogenesis of tendon calcification and tendinopathy. In this study, we found that the growth hormone-releasing hormone agonist (GA) can prevent matrix degradation and osteogenic differentiation in TSPCs. As oxidative stress is a key factor in the osteogenic differentiation of TSPCs, we used bovine serum albumin/heparin nanoparticles (BHNPs), which have biocompatibility and drug loading capacity, to scavenge reactive oxygen species (ROS) and achieve sustained release of GA at the site of inflamma-tion. The newly developed BHNPs@GA had a synergetic effect on reducing ROS production in TSPCs. In addition, BHNPs@GA effectively inhibited tendon calcification and promoted collagen formation in a rat model of tendinopathy. Focusing on the ROS underlying the differentiation and dedifferentiation of TSPCs, this work demonstrated that sustained release of GA targeting ROS and ectopic ossification is a practical therapeutic strategy for treating tendinopathy.
What problem does this paper attempt to address?